Last updated: 2026-10-13 09:16:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
electroCore, Inc. (ECOR) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9.12, with a market capitalisation of $87.09M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.41 to $12.70. This page covers its latest market performance, valuation, price trends and company information.
$87.09M | |
$9.78 | |
$303.45 | |
$2.92 | |
$9.66 | |
54.76K | |
81.09K | |
-- | |
$12.70 | |
$4.41 | |
-- | |
-- |
electroCore, Inc. (ECOR) is trading at $9.36 in pre-market trading as of 2026-10-12 23:31:00, down 3.06% ($0.30) from the previous close of $9.66
Pre-market trading shows how investors are pricing ECOR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, electroCore, Inc. (ECOR) moved from $10.14 to $9.12, representing a decline of 10.08% ($1.02).
The stock traded between $8.97 and $11.02 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 56.48 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 56.8%
ECOR is currently trading at $9.12, placing it 56.8% of the way from its 52-week low of $4.41 to its 52-week high of $12.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 83 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of electroCore, Inc. (ECOR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.